Mars, Incorporated Acquires Heska Corporation
April 3, 2023
Mars, Incorporated agreed to acquire Heska Corporation for $120.00 per share (approximately $1.3 billion equity value), bringing the veterinary diagnostics company into Mars Petcare's Science & Diagnostics business. The acquisition is intended to broaden Mars' point-of-care diagnostic offerings, accelerate R&D and innovation, and expand access to veterinary diagnostics for companion animal health globally.
- Buyers
- Mars, Incorporated
- Targets
- Heska Corporation
- Sellers
- Heska shareholders
- Industry
- Medical Devices
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Heska Corporation Acquires Lacuna Diagnostics
January 13, 2021
Healthcare Services
Heska Corporation announced an agreement to acquire 100% of Lacuna Diagnostics, a Fort Collins–based developer of point-of-care digital cytology and telemedicine pathology services for the veterinary market. The acquisition gives Heska immediate specialty clinical services capabilities — including a digital telemedicine cytology platform and an expert network of pathologists — and is intended to expand Heska's product and revenue streams to better serve veterinary customers.
-
Heska Corporation Acquires Biotech Laboratories U.S.A. LLC to Enter Rapid Assay Veterinary Diagnostics Market
September 1, 2021
Medical Devices
Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.
-
Mars Acquires Cerba HealthCare's Stake in Cerba Vet and ANTAGENE
July 2, 2024
Healthcare Services
Mars, Incorporated has completed its acquisition of Cerba HealthCare's ownership stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE. The two businesses will join Mars Petcare's Science & Diagnostics division to complement its existing veterinary diagnostics and genetic testing capabilities.
-
Mars Acquires Kellanova
December 11, 2025
Food & Beverage
Mars, Incorporated has acquired Kellanova in an all-cash transaction valued at $35.9 billion ($83.50 per share). The deal brings Kellanova's snack and breakfast brands — including Pringles, Cheez-It and Pop-Tarts — into the Mars Snacking portfolio to expand Mars' global snacking scale, capabilities and product categories.
-
Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health
January 18, 2024
Veterinary
Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.
-
Zomedica Corp Acquires Pulse Veterinary Technologies from Branford Castle Partners
October 1, 2021
Medical Devices
Zomedica Corp. acquired Pulse Veterinary Technologies (PulseVet) from Branford Castle Partners for $70.9 million in an all-cash transaction. PulseVet, an Alpharetta, Georgia-based manufacturer of veterinary shock wave therapy systems, expands Zomedica's device portfolio and adds companion-animal and equine treatment capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.